Skip to main content
. Author manuscript; available in PMC: 2014 Jun 1.
Published in final edited form as: J Neurosurg. 2013 Apr 12;118(6):1176–1180. doi: 10.3171/2013.3.JNS122282

Table 1.

IDH1 mutation incidence in tumor subtypes.4,5,14,16,18,21,25,26,29,32,35,36

Tumor Type Mutations (%) and median (range) Number of mutations/total number of tumors
Diffuse Astroctyoma 74% (0–88%) 307/407
Anaplastic Astrocytoma 59% (0–78%) 294/457
Secondary GBM 83% (50–100%) 94/121
Oligodendroglioma 76% (67–84%) 283/366
Anaplastic Oligodendroglioma 67% (49–94%) 237/355
Oligoastrocytoma 80% (50–100%) 153/196
Anaplastic Oligoastrocytoma 75% (63–94%) 245/345
Ganglioglioma 37.5% 3/8
Anaplastic Ganglioglioma 60% 3/5
Sporadic Paraganglioma 2% 1/66
Primitive Neuroectodermal Tumor 17% (0–33%) 3/17
Acute Myelogenous Leukemia 1% (0–9%) 21/389